Blinklab Limited (AU:BB1) has released an update.
BlinkLab Limited has announced a strategic partnership with Mental Care Group (MCG) to advance ADHD diagnostics using its innovative smartphone app for neurometric testing. This collaboration is set to improve diagnostic accuracy and efficiency through the app’s ability to objectively assess sensory sensitivity in ADHD patients. The partnership is also expected to expedite the path to regulatory approval in Europe and the US, and broaden the clinical adoption of BlinkLab’s technology.
For further insights into AU:BB1 stock, check out TipRanks’ Stock Analysis page.
